SCHEMBL3484534

SCHEMBL3484534

C[C@@](O)(CNC(=O)OCc1ccccc1)c1cc(F)cc(F)c1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HTT P42858 1/20 0.45
MGLL Q99685 2/20 0.44
L3MBTL1 Q9Y468 3/20 0.43
SYK P43405 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MAPT P10636 1/20 0.42
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
CTSS P25774 1/20 0.41
KCNA5 P22460 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3483668 0.88 MGLL (0.49) SMN1; SMN2LMNAMEN1KMT2AHTT
SCHEMBL18002248 0.80 SMN1; SMN2 (0.58) SMN1; SMN2LMNAMEN1KMT2AHTT
SCHEMBL15677565 0.78 SMN1; SMN2 (0.56) SMN1; SMN2LMNAMEN1KMT2AHTT
SCHEMBL13741500 0.78 SMN1; SMN2 (0.59) SMN1; SMN2LMNAMEN1KMT2AHTT
SCHEMBL2371661 0.78 MEN1 (0.58) SMN1; SMN2LMNAMEN1KMT2AHTT
SCHEMBL1644780 0.78 MEN1 (0.52) SMN1; SMN2LMNAMEN1KMT2AHTT
SCHEMBL2192192 0.76 SMN1; SMN2 (0.56) SMN1; SMN2LMNAHTTL3MBTL1SYK
SCHEMBL291124 0.76 SMN1; SMN2 (0.56) SMN1; SMN2LMNAMEN1KMT2AHTT
SCHEMBL8149899 0.75 LMNA (0.59) SMN1; SMN2LMNAMEN1KMT2AHTT
SCHEMBL21985416 0.74 SMN1; SMN2 (0.55) SMN1; SMN2LMNAMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257536-A2 CYCLIC DIARYL ETHER AS ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS Amira Pharmaceuticals, Inc. (US) 2010-12-08 EP disclosed
WO-2009102893-A2 CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors AMIRA PHARMACEUTICALS, INC. (US) 2009-08-20 WO disclosed